BioSpace News Archive

Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that it plans to advance SAGE-718, a novel, first-in-class, oxysterol-based positive allosteric modulator (PAM) of N-methyl-D-aspartate (NMDA) receptors, to a Phase 2 placebo-controlled clinical trial in patients with Huntington’s disease (HD).

Pepinemab (VX15), an experimental Vaccinex drug previously shown to prevent reduced brain glucose transport in Huntington’s disease, will be tested for similar effects in Alzheimer’s disease

RAPT Therapeutics, Inc. announced that Mary Ann Gray, Ph.D., President of Gray Strategic Advisors, LLC, has joined its Board of Directors.

Slayback Pharma LLC announced the final approval and launch in the United States of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection.

Digital integration allows members to seamlessly switch to PillPack for their pharmacy needs

Imperative Care, Inc. today announced that it has completed the initial closing of a Series C financing of $85 million to support the commercial launch of the company’s portfolio, which is composed of the latest advances in neurovascular devices treating ischemic and hemorrhagic strokes.

Clinical Study to Evaluate Device’s Ability to Prevent Amputation and Promote Wound Healing in Patients with No Other Options

Saebo’s flagship product, SaeboFlex, included in the newly created Medicine Wellcome Galleries revealing break-through medical treatment innovations spanning the last 500 years.

Progenity, a privately held biotechnology company, and Geisinger, one of the nation’s most innovative health services organizations, announced publication of a study in Obstetrics & Gynecology demonstrating the significant economic burden associated with preeclampsia.

With the frequency of severe disasters on the rise, hundreds of thousands of people in 2019 turned to the American Red Cross for food, shelter and recovery support.